Assessment of nodular goitre

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 1, 2010, Pages 51-61

  Tonacchera, Massimo ^a   Pinchera, Aldo ^a   Vitti, Paolo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

elastography; fine needle aspiration; hyperthyroidism; non toxic goitre; thyroid nodules; toxic adenoma TSH receptor; toxic multinodular goitre; TSH receptor; TSH receptor mutations; ultrasound

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN TYROSINE KINASE; RAF PROTEIN; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR PAX8;

ASPIRATION BIOPSY; CHROMOSOME REARRANGEMENT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ELASTOGRAPHY; ENVIRONMENTAL FACTOR; HUMAN; HYPERTHYROIDISM; INCIDENCE; NODULAR GOITER; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; POINT MUTATION; REVIEW; THYROID FUNCTION; THYROID MEDULLARY CARCINOMA; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

BIOPSY, FINE-NEEDLE; DIAGNOSTIC IMAGING; DIAGNOSTIC TECHNIQUES, ENDOCRINE; GOITER, NODULAR; HUMANS;

EID: 76749114896     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2009.08.008     Document Type: Review

References (69)

1. Wiersinga W.M. Management of non-toxic multinodular goiter. 1st edn. In: Wass J.A.H., and Shalet S.M. (Eds). Endocrinology and diabetes (2000), Oxford University Press, New York 557-564
2. Wang C., and Crapo L.M. The epidemiology of thyroid disease and implications for screening. Endocrinology and Metabolism Clinics of North America 26 (1997) 189-218
3. Marqusee E., Benson C.B., Frates M.C., et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Annals of Internal Medicine 133 (2000) 696-700
4. Knudsen N., Perrild H., Christiansen E., et al. Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. European Journal of Endocrinology 142 (2000) 224-230
5. Aghini-Lombardi F., Antonangeli L., Martino E., et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 561-566
6. TunbridgeWM, Evered D.C., Hall R., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology 7 (1977) 481-493
7. Vander J.B., Gaston E.A., and Dawber T.R. Significance of solitary nontoxic thyroid nodules. Preliminary report. The New England Journal of Medicine 251 (1954) 970
8. Baldwin D.B., and Rowett D. Incidence of thyroid disorders in Connecticut. The Journal of the American Medical Association 239 (1978) 742-744
9. Jarløv A.E., Hegedüs L., Gjørup T., et al. Observer variation in the clinical assessment of the thyroid gland. Journal of Internal Medicine 229 (1991) 159-161
10. Tan G.H., and Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Annals of Internal Medicine 126 (1997) 226-231
11. Belfiore A., La Rosa G.L., La Porta G.A., et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. American Journal of Medicine 93 (1992) 363-369
12. Krohn K., and Paschke R. Progress in understanding the etiology of thyroid autonomy. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 3336-3345
13. Baltisberger B.L., Minder C.E., and Burgi H. Decrease of incidence of toxic nodular goiter in a region of Switzerland after full correction of mild iodine deficiency. European Journal of Endocrinology 132 (1995) 546
14. Lauberg P., Pedersen K.M., Hreidarsson A., et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 765-769
15. Bottcher Y., Eszlinger M., Tonjes A., et al. The genetics of euthyroid familial goiter. Trends in Endocrinology and Metabolism (2005) 314-319
16. Hansen P.S. Genetic and environmental causes of individual differences in thyroid size: a study of healthy Danish twins. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 2071-2077
17. Brix T.H., Kyvik K.O., and Hegedüs L. Major role of genes in the etiology of simple goiter in females: a population-based twin study. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 3071-3075
18. Corral J., Martin C., Perez R., et al. Thyroglobulin gene point mutation associated with non-endemic simple goitre. Lancet 341 (1993) 462-464
19. Bignell G.R., Canzian F., Shayeghi M., et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. American Journal of Human Genetics 61 (1997) 1123-1130
20. Neumann S., Willgerodt H., Ackermann F., et al. Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na_/I_ symporter. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 3750-3756
21. McKay J.D., Williamson J., Lesueur F., et al. At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family. European Journal of Endocrinology 141 (1999) 122-125
22. Capon F., Tacconelli A., Giardina E., et al. G Mapping a dominant form of multinodular goiter to chromosome Xp22. American Journal of Human Genetics 67 (2000) 1004-1007
23. Dumont J.E., Lamy F., Roger P., et al. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiological Reviews 72 (1992) 667-697
24. Parma J., Duprez L., Van Sande J., et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365 (1993) 649-651
25. Paschke R., Tonacchera M., Van Sande J., et al. Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. The Journal of Clinical Endocrinology and Metabolism 79 (1994) 1785-1789
26. Van Sande J., Parma J., Tonacchera M., et al. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 2577-2585
27. Tonacchera M., Chiovato L., Pinchera A., et al. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating somatic thyrotropin receptor mutations with solitary toxic adenoma. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 492-498
28. Krohn K., Fuhrer D., Bayer Y., et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocrine Reviews 26 (2005) 504-524
29. Nogueira C.R., Kopp P., Arseven O.K., et al. Thyretropin receptor mutations in hyperfunctiong thyroid adenomas from Brazil. Thyroid 11 (1999) 1063-1068
30. Georgopoulos N.A., Sykiotis G.P., Sgourou A., et al. Autonomous functioning nodules in a former iodine deficient area commonly harbour gain-of-function mutations in the thyreotropin signaling pathway. European Journal of Endocrinology 149 (2003) 287-292
31. Palos Paz F., Perez Guerra O., Cameselle-Tejjeiro J., et al. Prevalence of mutations in TSHr, GNAS, PRKAR1A, and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. European Journal of Endocrinology 159 (2008) 623-631
32. Gabriel E.M., Bergert E.R., Grant C.S., et al. Germline polymorphisms of codon 727 of human thyretropin stimulating hormone receptor is associated with toxic multinodular goiter. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 3328-3335
33. Takeshita A., Nagayama Y., Yokoyama N., et al. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 2607-2610
34. Tonacchera M., Agretti P., Chiovato L., et al. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 2270-2274
35. Krohn K., Wohlgemuth S., Gerber H., et al. Hot microscopic areas of iodine-deficient euthyroid goiters contain constitutively activating TSH receptor mutations. The Journal of Pathology 192 (2000) 37-42
36. Refetoff S., Harrison J., Karanfilski B.T., et al. Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. The New England Journal of Medicine 292 (1975) 171-175
37. Shibata Y., Yamashita S., Masyakin V.B., et al. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet 358 (2001) 1965-1966
38. Bonnema S.J., Bennedbæk F.N., Wiersinga W.M., et al. Management of the nontoxic multinodular goitre: a European questionnaire study. Clinical Endocrinology 53 (2002) 5-12
39. Bonnema S.J., Bennedbæk F.N., Ladenson P.W., et al. Management of the nontoxic multinodular goiter: a North American survey. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 112-117
40. Cohen R., Campos J.M., Salaun C., et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). The Journal of Clinical Endocrinology and Metabolism 85 (2000) 919-922
41. Meier C.A. Thyroid nodules: pathogenesis, diagnosis and treatment. Baillière's Clinical Endocrinology and Metabolism 14 (2000) 559-575
42. Hahm J.R., Lee M.S., Min Y.K., et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11 (2001) 73-80
43. Vierhapper H., Raber W., Bieglmayer C., et al. Routine measurement of plasma calcitonin in nodular thyroid diseases. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 1589-1593
44. Rieu M., Lame M.C., Richard A., et al. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clinical Endocrinology 42 (1995) 453-460
45. Niccoli P., Wion-Barbot N., Caron P., et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 338-341
46. Pacini F., Fontanelli M., Fugazzola L., et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism 78 (1994) 826-829
47. Ozgen A.G., Hamulu F., Bayraktar F., et al. Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter. Thyroid 9 (1999) 579-582
48. Knudsen N., Bols B., Bulow I., et al. Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9 (1999) 1069-1074
49. Wiest P.W., Hartshorne M.F., Inskip P.D., et al. Thyroid palpation vs. high-resolution thyroid ultrasonography in the detection of nodules. Journal of Ultrasound in Medicine 17 (1998) 487-496
50. Ezzat S., Sarti D.A., Cain D.R., et al. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Archives of Internal Medicine 154 (1994) 1838-1840
51. Vitti P., and Rago T. Thyroid ultrasound as a predicator of thyroid disease. Journal of Endocrinological Investigation 26 (2003) 686-689
52. Rago T., Santini F., Scutari M., et al. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. The Journal of Clinical Endocrinology and Metabolism 92 (2007) 2917-2922
53. Hays M.T., and Wesselossky B. Simultaneous measurement of thyroidal trapping (99 mTcO4-) and binding (131I-): clinical and experimental studies in man. Journal of Nuclear Medicine 14 (1973) 785-792
54. Kumar A., Ahuja M.M., Chattopadhyay T.K., et al. Fine needle aspiration cytology, sonography and radionuclide scanning in solitary thyroid nodule. The Journal of the Association of Physicians of India 40 (1992) 302-306
55. Loy T.J., and Sundram F.X. Diagnostic management of solitary thyroid nodules. Annals of the Academy of Medicine, Singapore 6 (1989) 658-664
56. Ashcraft M.W., and Van Herle A.J. Management of thyroid nodules. Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head and Neck Surgery 3 (1981) 297-322
57. Christensen S.B., Bondeson L., Ericsson U.B., et al. Prediction of malignancy in the solitary thyroid nodule by physical examination, thyroid scan, fine-needle biopsy and serum thyroglobulin. A prospective study of 100 surgically treated patients. Acta Chirurgica Scandinavica 150 (1984) 433-439
58. Cox M.R., Marshall S.G., and Spence R.A. Solitary thyroid nodule: a prospective evaluation of nuclear scanning and ultrasonography. British Journal of Surgery 78 (1991) 90-93
59. Korun N., Asci C., Yilmazlar T., et al. Total thyroidectomy or lobectomy in benign nodular disease of the thyroid: changing trends in surgery. International Surgery 82 (1997) 417-419
60. Mazzaferri E.L. Management of a solitary thyroid nodule. The New England Journal of Medicine 328 (1993) 553-559
61. Gharib H., Goellner J.R., Zinsmeister A.R., et al. Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Annals of Internal Medicine 101 (1994) 25-28
62. Leenhardt L., Hejblum G., Franc B., et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 24-28
63. Danese D., Sciacchitano S., Farsetti A., et al. Diagnostic accuracy of conventional vs. sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 8 (1998) 15-21
64. Carmeci C., Jeffrey R.B., McDougall I.R., et al. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid 8 (1998) 283-289
65. Pelizzo M.R., Bernante P., Toniato A., et al. Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter. Tumori 83 (1997) 653-655
66. Tollin S.R., Mery G.M., Jelveh N., et al. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 10 (2000) 235-241
67. Papini E., Guglielmi R., Bianchini A., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 1941-1946
68. Ciampi R., and Nikiforov Y.E. RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology 148 (2007) 936-941
69. Nikiforova Y.E., Steward D.L., Robinson-Smith, et al. Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. The Journal of Clinical Endocrinology and Metabolism 94 (2009) 2092-2098